NCT00618735View on ClinicalTrials.gov

Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

July 31, 2010

Study Completion Date

December 31, 2010

Conditions
Advanced Solid Tumors
Interventions
DRUG

BIIB021

Dosage, frequency (once daily), and duration as specified in protocol. This dosing arm is currently on hold.

DRUG

BIIB021

Twice daily dosing

Trial Locations (3)

78229

Research Site, San Antonio

90404

Research Site, Santa Monica

92024

Research Site, Encinitas

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT00618735 - Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter